Lin, T. et al. 2022. Tenapanor: A new treatment option for hyperphosphatemia in end stage kidney disease. Journal of Pharmacy & Pharmaceutical Sciences. 25, (Jan. 2022), 77–83. DOI:https://doi.org/10.18433/jpps32284.